Effects of Clinicopathological Characteristics on the Survival of Patients Treated with PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy for Advanced Cancer: A Systemic Review and Meta-Analysis

BACKGROUND: PD-1/PD-L1 inhibitors have made unprecedented progress in the treatment of cancer. METHODS: A systemic search was conducted for randomized controlled trials that compared PD-1/PD-L1 inhibitor monotherapy or combination therapy with nonimmunotherapy. Hazard ratios (HRs) of overall surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yuhan, Li, Yongfu, Du, Qi, Peng, Xinyi, Jin, Jiangtao, Guo, Hong, Li, Yongyan, Li, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762667/
https://www.ncbi.nlm.nih.gov/pubmed/33381603
http://dx.doi.org/10.1155/2020/5269787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762667/
https://www.ncbi.nlm.nih.gov/pubmed/33381603
http://dx.doi.org/10.1155/2020/5269787

Ejemplares similares